- Home
- GENK vs IXHL Comparison
GENK vs IXHL Comparison
Compare GENK & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GENK
- IXHL
- Stock Information
- Founded
- GENK 2011
- IXHL 2001
- Country
- GENK United States
- IXHL Australia
- Employees
- GENK N/A
- IXHL N/A
- Industry
- GENK Restaurants
- IXHL
- Sector
- GENK Consumer Discretionary
- IXHL
- Exchange
- GENK Nasdaq
- IXHL Nasdaq
- Market Cap
- GENK 36.5M
- IXHL 39.2M
- IPO Year
- GENK 2023
- IXHL N/A
- Fundamental
- Price
- GENK $6.87
- IXHL $1.88
- Analyst Decision
- GENK Strong Buy
- IXHL
- Analyst Count
- GENK 3
- IXHL 0
- Target Price
- GENK $13.17
- IXHL N/A
- AVG Volume (30 Days)
- GENK 54.5K
- IXHL 24.0K
- Earning Date
- GENK 03-05-2025
- IXHL 11-14-2024
- Dividend Yield
- GENK N/A
- IXHL N/A
- EPS Growth
- GENK 483.78
- IXHL N/A
- EPS
- GENK 0.17
- IXHL N/A
- Revenue
- GENK $198,834,000.00
- IXHL $86,000.00
- Revenue This Year
- GENK $14.66
- IXHL $3,817.06
- Revenue Next Year
- GENK $21.47
- IXHL $66.67
- P/E Ratio
- GENK $41.10
- IXHL N/A
- Revenue Growth
- GENK 12.50
- IXHL N/A
- 52 Week Low
- GENK $5.61
- IXHL $1.50
- 52 Week High
- GENK $14.46
- IXHL $8.47
- Technical
- Relative Strength Index (RSI)
- GENK 34.31
- IXHL 50.66
- Support Level
- GENK $7.11
- IXHL $1.71
- Resistance Level
- GENK $7.54
- IXHL $1.93
- Average True Range (ATR)
- GENK 0.33
- IXHL 0.15
- MACD
- GENK -0.02
- IXHL 0.00
- Stochastic Oscillator
- GENK 4.39
- IXHL 35.51
About GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc is an Asian casual dining restaurant in the United States. It offers an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.